TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Allergan AS
Closing information (x1000 DKK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover |
20,648
|
21,660
|
29,521 |
Financial expenses |
50
|
24
|
26 |
Earnings before taxes |
1,961
|
2,011
|
3,311 |
Total assets |
14,132
|
12,115
|
12,561 |
Current assets |
14,132
|
12,115
|
12,561 |
Current liabilities |
3,536
|
3,150
|
4,999 |
Equity capital |
10,596
|
8,965
|
7,562 |
- share capital |
76
|
74
|
76 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency |
75.0%
|
74.0%
|
60.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
9.5%
|
9.3%
|
11.2% |
Return on assets (ROA) |
14.2%
|
16.8%
|
26.6% |
Current ratio |
399.7%
|
384.6%
|
251.3% |
Return on equity (ROE) |
18.5%
|
22.4%
|
43.8% |
Change turnover |
-1,385
|
-7,392
|
2,160 |
Change turnover % |
-6%
|
-25%
|
8% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.